Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (12): 1099-1100.DOI: 10.3969/j.issn.1673-8640.2016.12.020
• Orginal Article • Previous Articles
Received:2016-04-10
Online:2016-12-25
Published:2016-12-29
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.12.020
| 1 | 王兰兰. 医学检验项目选择与临床应用[M]. 北京:人民卫生出版社,2010:63-65. |
| 2 | 何海洪,许瑶,钟阳青,等. 激肽释放酶原缺乏症孕妇1例[J]. 广东医学,2015,53(2):184. |
| 3 | 王学锋,戴菁,王明山,等. 两个遗传性凝血因子Ⅻ缺陷症家系FⅫ基因突变分析[J]. 诊断学理论与实践,2005,4(6):447-450. |
| 4 | 常大雨,欧阳建,邵晓雁,等. 凝血因子Ⅻ46 C/T多态性一家系报道及相关文献复习[J]. 血栓与止血学, 2009, 15(4):154-157. |
| 5 | 郑卫东,姚志彬,刘艳辉,等. 人类凝血因子Ⅻ基因一种新突变的发现和确证[J]. 分子诊断与治疗杂志,2010,2(4):227-230. |
| 6 | 谢海啸,王明山,谢耀盛,等. 一个遗传性凝血因子Ⅻ缺陷症家系凝血因子Ⅻ基因分析[J]. 中华检验医学杂志,2010,33(4):300-304. |
| 7 | 邢志芳,戴菁,陆晔玲,等. 2例遗传性凝血因子Ⅻ缺陷症分子发病机制研究[J].中国输血杂志,2011,24(5):367-371. |
| 8 | 谢海啸,吕美艳,杨小丽,等. 四个遗传性凝血因子Ⅻ缺陷症家系基因分析[J]. 中华血液学杂志,2013,34(3):200-204. |
| 9 | 谢海啸,王莹宇,周武,等. 凝血因子Ⅻ缺陷症导致再发体外受精和胚胎移植失败原因2例分析[J]. 温州医科大学学报,2014,44(4):286-289. |
| 10 | 谢耀盛,谢海啸,王明山,等. 静脉血栓形成患者FⅫ基因多态性对凝血纤溶功能的影响[J]. 检验医学,2012,27(3):213-216. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
